SENVELGO® (velagliflozin oral solution)

SENVELGO® (velagliflozin oral solution) is the innovative, easy-to-give, once-daily liquid oral solution that makes treating feline diabetes more convenient for newly diagnosed felines.*†

SENVELGO® (velagliflozin oral solution): https://bit.ly/SENVELGO_PI

IMPORTANT SAFETY INFORMATION: SENVELGO® (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. BEFORE USING THIS PRODUCT, IT IS IMPORTANT TO READ THE ENTIRE PRODUCT INSERT, INCLUDING THE BOXED WARNING.

CATS TREATED WITH SENVELGO MAY BE AT AN INCREASED RISK OF DIABETIC KETOACIDOSIS OR EUGLYCEMIC DIABETIC KETOACIDOSIS, BOTH OF WHICH MAY RESULT IN DEATH. DEVELOPMENT OF THESE CONDITIONS SHOULD BE TREATED PROMPTLY, INCLUDING INSULIN ADMINISTRATION AND DISCONTINUATION OF SENVELGO.

DO NOT USE SENVELGO IN CATS WITH DIABETES MELLITUS WHO HAVE PREVIOUSLY BEEN TREATED WITH INSULIN, WHO ARE RECEIVING INSULIN, OR IN CATS WITH INSULIN-DEPENDENT DIABETES MELLITUS. The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death.

Sudden onset of hyporexia/anorexia, lethargy, dehydration, or weight loss in cats receiving SENVELGO should prompt immediate discontinuation of SENVELGO and assessment for diabetic ketoacidosis, regardless of blood glucose level. SENVELGO should not be initiated in cats with ketonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis.

Keep SENVELGO in a secure location out of reach of children, dogs, cats, and other animals to avoid accidental ingestion or overdose. FOR MORE SAFETY INFORMATION, PLEASE REFER TO THE PACKAGE INSERT.

*SENVELGO® (velagliflozin oral solution) prescribing information.
†SENVELGO® (velagliflozin oral solution) [Freedom of Information Summary; NADA 141-568]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2023.